Tactical Biomedical Technologies
Abstract
The Tactical Biomedical Technologies thrust will develop new approaches to deliver life-saving medical care on the battlefield. Uncontrolled blood loss is the leading cause of preventable death for soldiers on the battlefield. While immediate control of hemorrhage is the most effective strategy for treating combat casualties and saving lives, currently no method, other than surgical intervention, can effectively treat intracavitary bleeding. A focus in this thrust is the co-development of a materials-based agent(s) and delivery mechanism capable of hemostasis and wound control for non-compressible hemorrhage in the abdominal space, regardless of wound geometry or location within that space. This thrust will also investigate non-invasive techniques and equipment to use laser energy to treat intracranial hemorrhage through the skull and tissues in a pre-surgical environment. Finally, in order to address logistical delays associated with delivering necessary therapeutics to the battlefield, this thrust will also develop a pharmacy on demand that will provide a rapid response capability to enable far-forward medical providers the ability to manufacture and produce small molecule drugs and biologics.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2016
- Source ID
- 0c17ecbe9487b404a706a7319cbc4fda
Related Documents
- Root: BIOMEDICAL TECHNOLOGY